fbpx

Welcome, Yokogawa Innovation Switzerland!

As you might remember from our press release last summer, Yokogawa established Yokogawa Innovation Switzerland (YIS) in July 2020. We got the chance to speak to Tsuneji Sawai, the Managing Director of  Yokogawa Innovation Switzerland.

Aurelian Gogonea/ GettyImages

As you might remember from our press release last summer, Yokogawa established Yokogawa Innovation Switzerland (YIS) in July 2020. What has happened since then? Which new innovations can we expect from the new-founded organization?

We got the chance to speak to Tsuneji Sawai, the Managing Director of  Yokogawa Innovation Switzerland. In this exclusive interview, Sawai talks about the long-term goals of Yokogawa Innovation Switzerland and its significance for bioeconomy.

Tsuneji Sawai worked for more than twenty years for Yokogawa's R&D department before taking over the new role as the Managing Director of YIS.  

Focus areas of Yokogawa Innovation Switzerland

Tsuneji Sawai, Managing Director of Yokogawa Innovation Switzerland
Tsuneji Sawai, Managing Director of Yokogawa Innovation Switzerland

LIB Blog: Thank you for taking the time for an interview today, Mr. Sawai. Please tell us, on which areas will Yokogawa Innovation Switzerland primarily focus?

Tsuneji Sawai: We started with operations in August 2020, so our company is still very young.  First of all, our mission is to explore the attractive business and R&D field in the bioeconomy area. To achieve that effectively and efficiently, we need to raise awareness for the Yokogawa Life Innovation Business. We already have a successful Life Innovation Business in Europe with products for High Content Analysis (HCA) like CQ1 or CV8000 and our Confocal Spinning Disc Units (CSU).  With Yokogawa Fluid Imaging Technologies we have the Flowcam, a high-quality particle analyzer.  But not many people actually know that Yokogawa is not only active in Industrial Automation, but also in Life Science. It is our mission to help Yokogawa to gain more brand awareness under the collaboration with our LIB headquarter, Yokogawa Europe, and other partners.

The importance of biotechnology

Yokogawa Innovation Switzerland: Daisuke Nojima
Daisuke Nojima. Chief Science Officer at Yokogawa Innovation Switzerland

LIB Blog: Why is biotechnology so important for Yokogawa?

Tsuneji Sawai: In Yokogawa’s long-term business framework, a sustainable society is defined as one of the focus areas. Through our bioeconomy business and amongst other initiatives, we are working to achieve the sustainable development goals (SDGs) and contribute to the development of a circular economy. Bioeconomy is an important pillar for building a sustainable society. For the acquisition of biotechnology, Yokogawa has already taken steps such as investing in AlgaEnergy, a Spanish microalgae company, and Bloom Biorenewables, a Swiss biomass company that will certainly be featured in this blog as well. We always welcome partners under Yokogawa's slogan "Co-innovating tomorrow".

Basel is the number one place to be

Switzerland Innovation Park Basel

LIB Blog: Why did you choose Basel as your headquarter's place?

Tsuneji Sawai: Our headquarter of Yokogawa Innovation Switzerland is located in Allschwil, next to the city of Basel. Basel is the European center of biotechnology and Life Science. A lot of innovative biotech companies and start-ups are located here. So we are in the best company.

Good News

LIB Blog: I heard that you have to share some exciting news with us?

Tsuneji Sawai: Indeed. In the near future, we plan to establish a showroom for our Life Innovation Business products in Switzerland. It will be in the same building as Yokogawa Innovation Switzerland. We will have a shared laboratory for conducting Proof of Concepts (PoC).

From Japan to Switzerland

LIB Blog: You originally came from Japan. Now you relocated to Switzerland in November 2020. How does it feel to live in Switzerland?

Tsuneji Sawai:  After I started working in Basel, I realized that we had chosen the best place to work with the Life Science and Bioeconomy ecosystem.  An open innovation system is effectively working, and the government, academia, and industries are welcome to work with other entities.

Speaking of private life, Basel is a safe and convenient city for foreigners, and I am very much satisfied with life here. People are kind, honest, and earnest, and I can live and work comfortably.

Many thanks for this inspiring interview. If you'd like to know more about Yokogawa Innovation Switzerland, please visit their website.

Mailyn Schuermann

  • Share

  • Tweet

  • Post

More

You may also like

CYBERSECURITY / June 16, 2021

Cybersecurity in the Life Science Sector- Part 2

The prominent increase in Cybersecurity risks in the Life Science sector urges organizations to construct a risk management system to manage the risks effectively. It is pivotal for organizations to develop a Cybersecurity risk management system which is a key faculty for managing complexity and adapting changes to the new technologies.

Read more

LIFE SCIENCE GENERAL / June 8, 2021

Bioreactor: Unificate Data and Processes

To create unification of data and processes for labs, Yokogawa Life Business HQ and Securecell have partnered through the unique combination of the Yokogawa BR1000 Advanced Control Bioreactor System and the Securecell Lucullus Process Information Management System (Lucullus®). Learn more about this cooperation in our webinar!

Read more

LIFE SCIENCE GENERAL / June 7, 2021

Live-Cell Imaging: Highspeed with minimal Photobleaching

To explore the dynamics of living cells, live-cell imaging is one of the major techniques. It supports your study of the cell behavior towards external stimuli. The main challenge for live-cell imaging is to get high-quality images in a minimal time frame with reduced phototoxicity for living cells.

Read more

Write a comment


Did you like the blog article? Do you have any suggestions, questions, criticism? Discuss them with us here. We look forward to your comments.